The present work has been carried out to annotate the ameliorative effect of methanolic extract of leaves of Murraya koenigii in Azathioprine induced immunosuppression in mice. Healthy Swiss albino mice of either sex were divided into six groups (n=6). The control group of animals received 1% CMC solution as vehicle. AZP 50mg/kg b.w i.p was administered to animals in second group that served as disease control group. Levamisole was used as standard drug that was administered to group III at a dose of 50mg/kg b.w p.o. Groups IV, V, VI were given with 250, 500 & 750 mg/kg b.w of the extracts p.o. after the treatment period, Immunomodulatory activity of Murraya koenigii was evaluated by Delayed Type Hypersensitivity reaction, hematological parameters, Phagocytic index and determination of organ weights. Intraperitoneal administration of Azathioprine caused myelosupression and compromised immune responses. Methanolic extract of Murraya koenigii significantly increased DTH response when compared to control and disease control group. The extract also increased the Phagocytic index, WBC count and % neutrophills in a dose dependent manner. The obtained results were comparable with that of the standard drug Levamisole. The findings demonstrate that MK is a promising drug with a potent therapeutic value in stimulating the suppressed or weakened immune responses in laboratory animals and hence can act as a potent immunomodulator.
To compare the bioavailability and bioequivalence of two prasugrel formulations one as a test and the other was the standard. The study was performed according to a randomized, open label, balanced, two-treatment, two-period, two-sequence, single-dose, crossover under fasting period with minimum of seven days wash-out period and was evaluated in 20(+ 2 stand by) subjects. To analyse pharmacokinetic properties, the blood samples were drawn taken up to 36 h after dosing. Plasma concentration of prasugrel was determined using liquid chromatographytandem mass spectrometry method. Pharmacokinetic parameters tmax, Cmax, AUC0-t, AUC0-¥, t1/2 and λz (Kel) were tested for bioequivalence after log-transformation of data and non-parametric evaluation was done for ratios of tmax. The point estimates and 90 % confidence intervals (CI) for AUC0-t, AUC0-∞, and Cmax for active metabolite (R-138727) were 95. 82-105.18, 96.00-104.69 and 90.80-103.20 respectively. These results indicated that the two formulations of Prasugrel were bioequivalent in case of active metabolite (R-138727), thus may be prescribed interchangeably.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.